HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David K Wallace Selected Research

Retinopathy of Prematurity (Retrolental Fibroplasia)

10/2022Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.
1/2022Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants.
10/2021International Classification of Retinopathy of Prematurity, Third Edition.
10/2021Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.
5/2021SHORT-TERM COMPUTER-ASSISTED QUANTIFICATION OF PLUS DISEASE AFTER TREATMENT OF TYPE 1 RETINOPATHY OF PREMATURITY WITH INTRAVITREAL BEVACIZUMAB OR RETINAL LASER PHOTOCOAGULATION.
1/2021Quantitatively comparing weekly changes in retinal vascular characteristics of eyes eventually treated versus not treated for retinopathy of prematurity.
1/2021Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity.
1/2020Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity.
1/2020Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity.
12/2018A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David K Wallace Research Topics

Disease

33Retinopathy of Prematurity (Retrolental Fibroplasia)
10/2022 - 09/2007
18Amblyopia (Lazy Eye)
01/2020 - 11/2004
10Strabismus (Squint)
10/2022 - 01/2005
6Anisometropia
01/2020 - 06/2006
5Refractive Errors (Refractive Error)
10/2022 - 06/2006
5Hyperopia (Hypermetropia)
01/2020 - 06/2006
3Optic Atrophy
10/2022 - 12/2012
3Glaucoma
01/2020 - 08/2002
3Myopia
01/2020 - 06/2006
3Lacrimal Apparatus Diseases (Epiphora)
10/2008 - 03/2008
2Esotropia (Esophoria)
01/2021 - 02/2016
2Intraoperative Complications
01/2020 - 12/2016
2Exotropia (Exophoria)
01/2020 - 10/2016
2Astigmatism
01/2019 - 10/2007
2Infections
01/2019 - 10/2018
2Apnea
01/2018 - 04/2007
2Diabetic Retinopathy (Retinopathy, Diabetic)
12/2012 - 12/2012
2Cataract (Cataracts)
12/2011 - 08/2002
2Birth Weight (Birth Weights)
05/2011 - 04/2007
1Pseudophakia
06/2021
1Diplopia (Double Vision)
01/2021
1Multiple Sclerosis
12/2020
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
12/2020
1Neuromyelitis Optica (Devic's Disease)
12/2020
1Demyelinating Diseases (Demyelinating Disease)
12/2020
1Retinal Detachment (Retinal Detachments)
01/2020
1Ocular Hypertension (Glaucoma, Suspect)
01/2020
1Hypotension (Low Blood Pressure)
10/2018
1Hemorrhage
10/2018
1Necrotizing Enterocolitis
10/2018
1Arthrogryposis renal dysfunction cholestasis syndrome
09/2018
1Tachycardia (Tachyarrhythmias)
01/2018
1Bradycardia
01/2018
1Pain (Aches)
04/2017
1Postoperative Pain
04/2017
1Rupture
12/2016
1Bronchopulmonary Dysplasia
03/2016
1Fetal Growth Retardation (Intrauterine Growth Retardation)
03/2016
1Tonic Pupil
02/2016
1Vision Disorders (Hemeralopia)
12/2012
1Macular Edema
05/2012
1Retinal Hemorrhage
01/2012
1Epiretinal Membrane (Epiretinal Membranes)
09/2011
1Lacrimal Duct Obstruction
10/2008
1Graves Ophthalmopathy
09/2007
1Cysts
08/2002

Drug/Important Bio-Agent (IBA)

19Retinaldehyde (Retinal)IBA
10/2022 - 09/2007
9Bevacizumab (Avastin)FDA Link
10/2022 - 01/2017
5AtropineFDA LinkGeneric
02/2015 - 11/2004
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 12/2016
3Mydriatics (Cycloplegics)IBA
01/2020 - 12/2011
2Ophthalmic Solutions (Eye Drops)IBA
02/2015 - 02/2005
1AntibodiesIBA
12/2020
1Myelin-Oligodendrocyte GlycoproteinIBA
12/2020
1cyclo(Arg-Pro) (CI 4)IBA
01/2020
1Methicillin (Metin)FDA Link
01/2019
1Inositol (Myoinositol)IBA
10/2018
1Oxygen (Dioxygen)IBA
01/2018
1Hypromellose DerivativesIBA
04/2017
1Local AnestheticsIBA
04/2017
1Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric
04/2017
1Lidocaine (Xylocaine)FDA LinkGeneric
04/2017
1SaltsIBA
04/2017
1SolutionsIBA
04/2017
1Capsules (Microcapsules)IBA
12/2016
1Pharmaceutical PreparationsIBA
12/2016
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2016
1Type A Botulinum Toxins (Botox)FDA Link
02/2016
1Levodopa (L Dopa)FDA LinkGeneric
05/2015
1Melanins (Melanin)IBA
06/2013

Therapy/Procedure

12Lasers (Laser)
10/2021 - 08/2008
6Therapeutics
10/2021 - 06/2006
6Telescopes
01/2021 - 01/2005
6Eyeglasses (Spectacles)
01/2019 - 06/2006
4Aftercare (After-Treatment)
10/2021 - 11/2013
4Operative Surgical Procedures
01/2020 - 03/2008
2Intraocular Lenses (Intraocular Lens)
12/2016 - 04/2009
2Lenses
10/2016 - 06/2006
1Posterior Capsulotomy
06/2021
1Light Coagulation
05/2021
1Vitrectomy
01/2020
1Anesthesia
04/2017
1Mechanical Ventilators (Ventilator)
03/2016
1Laser-Assisted Subepithelial Keratectomy (LASEK)
04/2009
1Refractive Surgical Procedures
04/2009
1Photorefractive Keratectomy
04/2009
1Laser In Situ Keratomileusis (LASIK)
04/2009
1Excimer Lasers
04/2009
1Catheters
10/2008
1Suture Techniques
09/2007
1Length of Stay
04/2007
1Artificial Respiration (Mechanical Ventilation)
04/2007
1Retinoscopes
06/2006
1Iridectomy
08/2002